Figure 2 Power of likelihood ratio, log-rank, and Fisher’s exact tests as a function of the relative risk (RR) for different proportions of susceptible.

Slides:

Advertisements

Similar presentations

Calculating sample size for a case-control study

Advertisements

American Academy of Pediatrics, Committee on Infectious Diseases. Policy Updated Recommendations on the Use of Meningococcal Vaccines Pediatrics. doi:

Table 5 Characteristics of 12 patients who had 1 test of stool samples that yielded positive results in the prospective clinical assessment for investigation.

Table 3 Titers of antibody to hepatitis B surface antigen (anti-HBs) 2–4 weeks after the first vaccination From: Response to Hepatitis B Vaccine in HIV-1–Positive.

Table 1. Baseline Characteristics of the 36,636 Study Subjects

Figure 1. Varicella-related outpatient visit rates by age group, MarketScan 2003–2012. Varicella was the primary diagnosis code for data shown. Annual.

Figure 1. Disposition of study participants, by group. Data are no

Table 6 The results of virus isolation tests before and after oseltamivir therapy. From: A Comparison of the Effectiveness of Oseltamivir for the Treatment.

Table 4 Results of 3 pairwise comparisons of expanded virus groups, by use of least-squares means differences and the Tukey honestly significant difference.

Figure 1. Shiga toxin–producing Escherichia coli (STEC) isolates by method of initial detection and STEC serotype, Connecticut, 2000–2009. From: Ten-Year.

Table 1 Groups of subjects in a study of the association between antibiotic use and colonization with resistant pneumococci. From: Measuring and Interpreting.

Table 1 Characteristics of patients at enrollment who received artesunate-amodiaquine (ASAQ) or artemether-lumefantrine (AL) for treatment of malaria.

Table 1 Characteristics of the 968 Women in the Study Group

Table 1 Demographic and clinical characteristics of 758 admitted patients for whom cultures of nares were performed to assess methicillin-resistant Staphylococcus.

Table 3. Predictors of Nevirapine Reactions at Antiretroviral Therapy Initiation From: Strategies for Nevirapine Initiation in HIV-Infected Children Taking.

Table 4 Comparison of frequencies of Legionella pneumophila serogroup 1 urinary antigen results and antibody titer results among patients with Pontiac.

From: Rotarix: A Rotavirus Vaccine for the World

Figure 3. Estimated liver parasite load on day 6

Open Forum Infect Dis. 2014;1(suppl_1):S13-S14. doi: /ofid/ofu051.37

Neonatal tetanus elimination in Pakistan: progress and challenges

Table 4. Effect of vaccination status on serogroup C serum bactericidal antibody (SBA) titers, IgG levels, and avidity indices (AIs) in acute and convalescent.

Figure 4 Monthly all-cause (A-C) and pneumonia and influenza (P&I) mortality rates among Japanese children aged 5–9 years. Vertical dotted lines, January.

Table 1 Criteria for proven invasive fungal disease except for endemic mycoses. From: Revised Definitions of Invasive Fungal Disease from the European.

Table 1 Characteristics of study population, by pneumococcal vaccination status. From: Prior Pneumococcal Vaccination Is Associated with Reduced Death,

From: Postinfectious Irritable Bowel Syndrome

Figure 1 Adverse events after typhoid fever vaccination reported to the Vaccine Adverse Events Reporting System, by vaccination date and vaccine type,

Figure 1 Timed kil curves

Volume 66, Issue 1, Pages (July 2004)

Supplementary Figure 2. Kinetics of HIV-specific IgG in the plasma over time in the tenofovir and placebo arms from 3 months to 39 months post-infection.

Table 5 Sample format for results of Streptococcus pneumoniae isolate testing in a laboratory that routinely performs only oxacillin disk tests for penicillin.

Table 1 Baseline (before receipt of antiretroviral prophylaxis) characteristics of the pregnant women (transmitting or nontransmitting mothers included.

Figure 1 Annual per-capita consumption of all fermented milks and yogurt only in selected countries in Europe and North America [3, 4]. From: Probiotic.

Table 2. Mean intrasubject diversity for the 11 study participants, by genomic region. From: Hepatitis C Virus (HCV) Diversity in HIV-HCV-Coinfected Subjects.

Systematic review of hepatocellular carcinoma mortality rates among hepatitis B virus- infected renal transplant recipients, with supplemental analyses.

Blinded, multicenter quality control study for the quantification of human immunodeficiency virus type 1 RNA in plasma by the Belgian AIDS reference.

Carbapenem resistance and mortality in patients with Acinetobacter baumannii infection: systematic review and meta-analysis E.V. Lemos, F.P. de la Hoz,

Monitoring rare events during an ongoing clinical trial

Statistical Deconvolution for Superresolution Fluorescence Microscopy

R. Cantón Clinical Microbiology and Infection

Optimized Group Sequential Study Designs for Tests of Genetic Linkage and Association in Complex Diseases Inke R. König, Helmut Schäfer, Hans-Helge Müller,

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

F. Schaumburg, U. Ateba Ngoa, K. Kö sters, R. Köck, A. A. Adegnika, P

Brian J Coburn, Sally Blower The Lancet Infectious Diseases

Design and powering of cystic fibrosis clinical trials using pulmonary exacerbation as an efficacy endpoint D.R. VanDevanter, A. Yegin, W.J. Morgan,

Transmitted drug-resistance in human immunodeficiency virus-infected adult population in El Salvador, Central America Á. Holguín, G. Yebra, L. Martín,

Systematic review or meta-analysis

Prevalence of tuberculosis, hepatitis C virus, and HIV in homeless people: a systematic review and meta-analysis Ulla Beijer, PhD, Achim Wolf, MSc, Dr.

A. Solé, P. Morant, M. Salavert, J. Pemán, P. Morales

Virus shedding after human rhinovirus infection in children, adults and patients with hypogammaglobulinaemia V. Peltola, M. Waris, L. Kainulainen, J.

P.L. Lopalco, P. Carrillo Santisteve

Training for the infectious diseases speciality in Norway

Arpita Ghosh, Fei Zou, Fred A. Wright

A Flexible Bayesian Framework for Modeling Haplotype Association with Disease, Allowing for Dominance Effects of the Underlying Causative Variants Andrew.

Meta-Analysis of Hepatitis C Virus Vaccine Efficacy in Chimpanzees Indicates an Importance for Structural Proteins Harel Dahari, Stephen M. Feinstone,

Random-Effects Model Aimed at Discovering Associations in Meta-Analysis of Genome- wide Association Studies Buhm Han, Eleazar Eskin The American Journal.

Gender differences in treatment outcomes of tuberculosis patients in Taiwan: a prospective observational study J.-Y. Feng, S.-F. Huang, W.-Y. Ting, Y.-C.

Erythromycin susceptibility of viridans streptococci from the normal throat flora of patients treated with azithromycin or clarithromycin King A. , Bathgate.

The Genetics of Major Depression

Volume 19, Issue 3, Pages (March 2016)

Higher CD34+ and CD3+ Cell Doses in the Graft Promote Long-Term Survival, and Have No Impact on the Incidence of Severe Acute or Chronic Graft-versus-Host.

Brucella detection in blood: comparison of the BacT/Alert standard aerobic bottle, BacT/Alert FAN aerobic bottle and BacT/Alert enhanced FAN aerobic bottle.

Volume 158, Issue 5, Pages (August 2014)

Jon Wakefield The American Journal of Human Genetics

Stephen C. Pratt, Mark J. Daly, Leonid Kruglyak

Benjamin A. Rybicki, Robert C. Elston

Clinical Microbiology and Infection

Volume 67, Issue 3, Pages (March 2005)

J.A. Pérez-Molina, F. Fernández Clinical Microbiology and Infection

Prediction in idiopathic membranous nephropathy

Michael P. Epstein, Richard Duncan, Erin B. Ware, Min A

Presentation transcript:

Figure 2 Power of likelihood ratio, log-rank, and Fisher’s exact tests as a function of the relative risk (RR) for different proportions of susceptible animals. Solid lines denote the likelihood ratio test; long dashes, the log-rank test; and short dashes, Fisher’s exact test. Simulations assume equal allocation to the vaccine and control arms of the study, a total sample size of N=50, a c<sub>max</sub> (maximum no. of challenges per animal) of 10, and p<sub>0</sub>=0.5 as the per-challenge probability of infection for control animals. The horizontal gray line denotes the significance level α=0.05 From: Power to Detect the Effects of HIV Vaccination in Repeated Low-Dose Challenge Experiments J Infect Dis. 2009;200(4):609-613. doi:10.1086/600891 J Infect Dis | © 2009 by the Infectious Diseases Society of America 1